- Nordic Nanovector Awarded NOK 12 Million in Funding From the Norwegian Research Council to Advance Alpha37, a Targeted Alpha Therapy for B-cell Cancers
- Nordic Nanovector Provides Update on LYMRIT 37-05 Phase 1 DLBCL Trial
- Nordic Nanovector ASA: Allocation of PSUs
- Nordic Nanovector: New preclinical Data Offer Insights Into Enhancing Betalutin®-Based Therapies in NHL
- Nordic Nanovector ASA - Financial Calendar
- Nordic Nanovector ASA - Results for the Third Quarter 2019
- Nordic Nanovector to Participate in Four Upcoming Investor Conferences
- Nordic Nanovector ASA: Invitation to Third Quarter 2019 Results Presentation and Webcast
Nordic Nanovector ASA (NANOo:STO) closed at 25.96, 23.85% above the 52 week low of 20.96 set on Oct 31, 2019.
20.96Oct 31 201946.98Apr 08 2019
Markit short selling activity
|Market cap||1.57bn NOK|
|EPS (TTM)||-7.23 |
Data delayed at least 15 minutes, as of Jan 23 2020 17:00 GMT.